MEET US AT ISPOR!
The Vitaccess team is excited to share new findings of its digital studies in Melanoma and rare diseases Charcot-Marie-Tooth and Beta-Thalassemia at ISPOR Europe in Copenhagen, 2-6 November.
We will also present a short- course on Saturday 2 November in the afternoon.
Come and say hello at our poster presentations to discover more about our patient-centric studies and visit our booth C2-025 to have a chat on how we can help you!
Please note: all times are in local time
Saturday, 2 November: 13:00-17:00
Short-course presentation by Dr Mark Larkin, Jon Spinage and Dr Annabel Nixon
Digital real-world evidence generation approaches in rare diseases and oncology
Monday, 4 November: 15:30-18:00
PCN265: Targeted review of adverse events associated with treatments for stage 3 and 4 Melanoma
PCN188: The cost-effectiveness of supplemental parenteral nutrition in oncology
Wednesday, 6 November: 09:30-14:00
PRO37: Healthcare resource use in Charcot-Marie-Tooth disease in the EU and US: interim results from an international digital real-world study
PRO93: Demographics and treatment patterns for Charcot-Marie-Tooth disease in the EU and US: interim results from an international digital real-world study
PRO116: Understanding the role of real-world evidence in Health Technology Assessment for orphan drugs
PRO136: Patient-reported burden of transfusion-dependent Beta-Thalassemia in the USA and UK measured using a digital app
PRO138: Productivity losses in people with Charcot-Marie-Tooth disease in the EU and US: interim results from an international digital real-world evidence study